DHX37 and rectum adenocarcinoma: Interestingly, the high expression of DHX37 was associated with favorable prognosis in lung squamous cell carcinoma, rectum adenocarcinoma, stomach adenocarcinoma, uterine corpus endometrial carcinoma, and thyroid carcinoma, which seemed to be not consistent with its role in cancer immune.